Błoński, P.J.; Czarnecka, A.M.; Ostaszewski, K.; Szumera-Ciećkiewicz, A.; Rutkowski, P.
Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma. Biomedicines 2024, 12, 669.
https://doi.org/10.3390/biomedicines12030669
AMA Style
Błoński PJ, Czarnecka AM, Ostaszewski K, Szumera-Ciećkiewicz A, Rutkowski P.
Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma. Biomedicines. 2024; 12(3):669.
https://doi.org/10.3390/biomedicines12030669
Chicago/Turabian Style
Błoński, Piotr J., Anna M. Czarnecka, Krzysztof Ostaszewski, Anna Szumera-Ciećkiewicz, and Piotr Rutkowski.
2024. "Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma" Biomedicines 12, no. 3: 669.
https://doi.org/10.3390/biomedicines12030669
APA Style
Błoński, P. J., Czarnecka, A. M., Ostaszewski, K., Szumera-Ciećkiewicz, A., & Rutkowski, P.
(2024). Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma. Biomedicines, 12(3), 669.
https://doi.org/10.3390/biomedicines12030669